2012
DOI: 10.1007/s10620-012-2223-3
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Mucosal Resection of an Epstein–Barr Virus-Associated Lymphoepithelioma-Like Gastric Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 5 publications
0
6
0
Order By: Relevance
“…Shin et al reported the clinicopathological features of 70 early GCLS patients and showed an extremely low rate of LNM, as well as the tendency for the macroscopic type, tumor location, and tumor size [30]. With its low likelihood of LNM, endoscopic resection has been suggested as an alternative treatment option for early GCLS patients [17][18][19]. However, despite the favorable prognosis of early GCLS, it remains unclear whether AGCLS also shows a favorable prognosis and similar clinicopathological features.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Shin et al reported the clinicopathological features of 70 early GCLS patients and showed an extremely low rate of LNM, as well as the tendency for the macroscopic type, tumor location, and tumor size [30]. With its low likelihood of LNM, endoscopic resection has been suggested as an alternative treatment option for early GCLS patients [17][18][19]. However, despite the favorable prognosis of early GCLS, it remains unclear whether AGCLS also shows a favorable prognosis and similar clinicopathological features.…”
Section: Discussionmentioning
confidence: 99%
“…There have been several reports demonstrating the favorable prognosis of GCLS compared with other gastric adenocarcinomas, as well as its differentiating clinicopathological features [11][12][13][14][15][16]. With its low frequency of lymph node metastasis (LNM), an expanded indication of endoscopic resection in early GCLS cases has been suggested [17][18][19][20]. However, to our knowledge, current information on GCLS including its clinicopathological features, survival outcomes, and treatment remains inadequate with only a few studies owing to its rarity [13].…”
Section: Introductionmentioning
confidence: 99%
“…There are several previous case reports that describe gastric LELC as a submucosal mass on macroscopic observation, endoscopy or other imaging modalities, such as endoscopic ultrasound or CT [5][6][7][8][9]. However, at our institution, we have observed several gastric LELCs that show various morphological distributions, including submucosal mass-like lesions with features that overlap with other gastric submucosal tumours.…”
Section: Introductionmentioning
confidence: 60%
“…In that study, it was reported that the expansive growth of tumour cells with lymphoid infiltration enabled them to be recognized as submucosal nodules, and they also proposed that EBV-associated EGC might form nodules after invading the submucosal layer. Other studies and case reports with endoscopic and pathological evaluations of EBVassociated gastric carcinoma reported submucosal nodules with lymphocytic infiltration [6,[15][16][17][18]. In addition, all of the reported tumours presented as submucosal tumours, except for two lesions which were classified as EGC.…”
Section: Discussionmentioning
confidence: 82%
“…The patients with this variant tumor can be good candidates for EMR in regard to a lower frequency of lymph node metastasis and a relative well circumscribed tumor margin that can be easily assessed endoscopically. Some clinical trials to remove EBVassociated LELCS in an early stage have been reported using an endoscopic resection such as EMR or submucosal dissection [36,37]. The patients treated with endoscopic resection have shown a benign clinical course without recurrence or metastasis.…”
Section: Introductionmentioning
confidence: 99%